Skip to main content

Lenard Boggio and Paul Terry

Genome British Columbia has appointed Lenard Boggio and Paul Terry to its board of directors. Boggio currently serves as an independent director on the boards of several publicly listed companies, and serves as commissioner of the Financial Institutions Commission of British Columbia. Before, he served as president of the Institute of Chartered Accountants of British Columbia (now the Chartered Professional Accountants of British Columbia), and the chair of the Canadian Institute of Chartered Accountants. Terry is currently the president and CEO of PHEMI, an adjunct professor at Simon Fraser University, and a partner with Magellan Angel Partners. Previously he served as the secretary/treasurer and technology adviser for the Michael Smith Foundation for Health and Research, and was one of the entrepreneurs-in-residence at SFU Venture Labs.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.